Rather than a research prospectus, the new review presents our vision, key facts and figures about the ¹û½´ÊÓƵ and our performance in 2021 and 2022, shares highlights and recognises the achievements of people who received awards, before providing updates from each of our three research programmes: Immunology, Signalling and Epigenetics. Five spotlight features (highlighted below) bring the ¹û½´ÊÓƵ’s research to life, focusing on individual research groups, particularly those new to the ¹û½´ÊÓƵ, and exploring their work in relation to the ¹û½´ÊÓƵ’s central mission of undertaking world-leading research to deliver lifelong health.
You can browse the 2021-2022 research report using the reader below or download the PDF version in full. The downloadable pdf file includes the following accessibility features: alternative text for images and symbols, auto tagging, and a manually curated reading order to ensure that screen readers follow a logical reading order. If you have any questions about the report or feedback on how the accessibility of the report can be improved, please contact comms@babraham.ac.uk.
Joining a new organisation and building your research team during a pandemic isn’t ideal but new group leader Dr Ian McGough is pleased he’s found his niche, and gorgeous trail running routes, alongside a very warm welcome.
Dr Philipp Voigt joined the ¹û½´ÊÓƵ in December 2021 to set up a new group in the Epigenetics programme. But on leaving school he wanted to teach maths and Latin. Here, he explains the biological conundrums he aims to answer – and why Latin grammar could yet come in handy.
Dr Arianne Richard talks about T cells, how knowing more about how they operate could open up new vaccines against viruses and new therapies for cancer, and why the ¹û½´ÊÓƵ is the best place for her to tackle these questions.
Dr Della David reflects on her first 12 months at the ¹û½´ÊÓƵ, reveals the roots of her own scientific curiosity, and explains how a tiny, transparent, short-lived worm is enabling her to discover new ways of promoting healthy ageing.
Dr Peter Rugg-Gunn talks about the challenges of studying early human development, his group’s groundbreaking discoveries, and why he believes the Human Development Biology Initiative – a five year, £10m project funded by Wellcome – will lead to a step change in the field.